By Tom Zanki ( November 20, 2014, 5:05 PM EST) -- Canadian drug giant Valeant Pharmaceuticals International Inc. has approved the repurchase of $2 billion in securities, outlining the plans to boost shareholder value Thursday — just days after its $55 billion bid to buy Botox maker Allergan Inc. fell through....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.